Search - tctmd.com

Displaying 41 - 60 of 112

Sort: Relevancy | Date

News Daily News

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

Yael L. Maxwell

January 26, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

Yael L. Maxwell

September 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Yael L. Maxwell

December 11, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

Advertisement

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

TCTMD’s Top 10 Most Popular Stories for August 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Most Stable Angina Patients Not Taking First-line Meds

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content